Download PDF
Thromb Haemost 2001; 85(06): 1066-1070
DOI: 10.1055/s-0037-1615965
Review Article
Schattauer GmbH

Polymorphisms in the Prothrombin Gene and their Association with Plasma Prothrombin Levels

H. Ceelie
1   Haemostasis and Thrombosis Research Centre, Dept. of Haematology, Leiden, The Netherlands
,
R. M. Bertina
1   Haemostasis and Thrombosis Research Centre, Dept. of Haematology, Leiden, The Netherlands
,
A. van Hylckama Vlieg
1   Haemostasis and Thrombosis Research Centre, Dept. of Haematology, Leiden, The Netherlands
2   Dept. of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands
,
F. R. Rosendaal
1   Haemostasis and Thrombosis Research Centre, Dept. of Haematology, Leiden, The Netherlands
2   Dept. of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands
,
H. L. Vos
1   Haemostasis and Thrombosis Research Centre, Dept. of Haematology, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 28 September 2000

Accepted after resubmission 31 January 2001

Publication Date:
12 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

To find genetic causes of high plasma prothrombin levels, an established prothrombotic risk factor, we searched for sequence variations in the prothrombin gene. We selected subjects with the 20210-GG genotype (since the 20210-A allele is already known to be associated with high levels) and elevated prothrombin levels (≥ 130 U/dl) from the Leiden Thrombophilia Study (LETS). No mutations were found in the 1 kb promoter region of the prothrombin gene in seven individuals with an isolated high prothrombin level. Comparison of the allelic frequencies of four different polymorphisms in the prothrombin gene in healthy volunteers and in the control subjects among the selected LETS individuals indicated a higher frequency of the 19911-G allele in the latter group (allele frequency 52 vs. 78%, respectively). Homozygous carriers of the 19911-G allele had 8 U/dl higher plasma prothrombin levels than 19911-AA carriers. This difference in prothrombin levels did not affect the thrombotic risk in 20210-GG carriers. In heterozygous 20210-A carriers the odds ratio increased from 1.6 (95% CI: 0.6-4.3) in subjects with 19911-A to 4.7 (1.6-14.0) in subjects with 19911-G on the other prothrombin allele.

Key words

Prothrombin - G20210A - A19911G - venous thrombosis
 

  • References

  • 1 Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost 1999; 82: 165-74.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Royle NJ, Irwin DM, Koschinsky ML, MacGillivray RT, Hamerton JL. Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively. Somat Cell Mol Genet 1987; 13: 285-92.
    CrossrefPubMedGoogle Scholar
  • 3 Degen SJ, Davie EW. Nucleotide sequence of the gene for human prothrombin. Biochemistry 1987; 26: 6165-77.
    CrossrefPubMedGoogle Scholar
  • 4 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
    PubMedGoogle Scholar
  • 5 Arruda VR, Annichino-Bizzacchi JM, Gonçalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997; 78: 1430-3.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Brown K, Luddington R, Williamson D, Baker P, Baglin T. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. Br J Haematol 1997; 98: 907-9.
    CrossrefPubMedGoogle Scholar
  • 7 Corral J, Gonzalez-Conejero R, Lozano ML, Rivera J, Heras I, Vicente V. The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. Br J Haematol 1997; 99: 304-7.
    CrossrefPubMedGoogle Scholar
  • 8 Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CR. The prothrombin gene G20210A variant: prevalence in a U. K. anticoagulant clinic population. Br J Haematol 1997; 98: 353-5.
    CrossrefPubMedGoogle Scholar
  • 9 Hillarp A, Zoller B, Svensson PJ, Dahlbäck B. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1998; 78: 990-2.
    PubMedGoogle Scholar
  • 10 Leroyer C, Mercier B, Oger E, Chenu E, Abgrall JF, Férec C, Mottier D. Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost 1998; 80: 49-51.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Margaglione M, Brancaccio V, Giuliani N, D’Andrea G, Cappucci G, Iannaccone L, Vecchione G, Grandone E, Di Minno G. Increased risk for venous thrombosis in carriers of the prothrombin G—>A20210 gene variant. Ann Intern Med 1998; 129: 89-93.
    CrossrefPubMedGoogle Scholar
  • 12 Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998; 338: 1793-7.
    CrossrefPubMedGoogle Scholar
  • 13 Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999; 99: 999-1004.
    CrossrefPubMedGoogle Scholar
  • 14 Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population. Thromb Haemost 1999; 82: 1395-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Rosendaal FR, Doggen CJM, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, Ardissino D, Palareti G, Bernardi F. The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler Thromb Vasc Biol 1997; 17: 2418-22.
    CrossrefPubMedGoogle Scholar
  • 17 Kyrle PA, Mannhalter C, Béguin S, Stümpflen A, Hirschl M, Weltermann A, Stain M, Brenner B, Speiser W, Pabinger I, Lechner K, Eichinger S. Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene. Arterioscler Thromb Vasc Biol 1998; 18: 1287-91.
    CrossrefPubMedGoogle Scholar
  • 18 Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, Bayliss P, Peake IR, Miller GJ. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 1997; 78: 1426-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Simioni P, Tormene D, Manfrin D, Gavasso S, Luni S, Stocco D, Girolami A. Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. Br J Haematol 1998; 103: 1045-50.
    CrossrefPubMedGoogle Scholar
  • 20 Corral J, Zuazu-Jausoro I, Rivera J, González-Conejero R, Ferrer F, Vicente V. Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family. Br J Haematol 1999; 105: 560-3.
    CrossrefPubMedGoogle Scholar
  • 21 Soria JM, Almasy L, Souto JC, Tirado I, Borell M, Mateo J, Slifer S, Stone W, Blangero J, Fontcuberta J. Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis. Blood 2000; 95: 2780-5.
    PubMedGoogle Scholar
  • 22 Koster T, Rosendaal FR, De Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-6.
    CrossrefPubMedGoogle Scholar
  • 23 Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briët E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms – the Leiden Thrombophilia Study (LETS). Thromb Haemost 1994; 71: 719-22.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Koster T, Rosendaal FR, Briët E, Vandenbroucke JP. John Hageman’s factor and deep-vein thrombosis: Leiden Thrombophilia Study. Br J Haematol 1994; 87: 422-4.
    CrossrefPubMedGoogle Scholar
  • 25 Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-5.
    CrossrefPubMedGoogle Scholar
  • 26 Koster T, Rosendaal FR, Briët E, van der Meer FJ, Colly LP, Trienekens PH, Poort SR, Reitsma PH, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood 1995; 85: 2756-61.
    PubMedGoogle Scholar
  • 27 De Visser MCH, Poort SR, Vos HL, Rosendaal FR, Bertina RM. Factor X promoter polymorphisms, factor X levels and the risk of venous thrombosis. Thromb Haemost. 1999 suppl: 508 (abstract).
    PubMedGoogle Scholar
  • 28 Rosendaal FR, Grant PJ, Ariëns R. A.S. Poort SR Bertina RM Factor XIIIVal34Leu, factor XIII antigen and activity levels and risk of venous thrombosis. Thromb Haemost. 1999 suppl: 508 (abstract).
    PubMedGoogle Scholar
  • 29 Meijers JCM, Tekelenburg WLH, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342: 696-701.
    CrossrefPubMedGoogle Scholar
  • 30 Kamphuisen PW, Rosendaal FR, Eikenboom JCJ, Bos R, Bertina RM. Factor V antigen levels and venous thrombosis: Risk profile, interaction with factor V Leiden and relation with factor VIII antigen levels. Arterioscler Thromb Vasc Biol 2000; 20: 1382-6.
    CrossrefPubMedGoogle Scholar
  • 31 van Tilburg NH, Rosendaal FR, Bertina RM. Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood 2000; 95: 2855-9.
    PubMedGoogle Scholar
  • 32 van Hylckama Vlieg A, Van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000; 95: 3678-82.
    PubMedGoogle Scholar
  • 33 Bancroft JD, Schaefer LA, Degen SJ. Characterization of the Alu-rich 5′-flanking region of the human prothrombin-encoding gene: identification of a positive cisacting element that regulates liver-specific expression. Gene 1990; 95: 253-60.
    CrossrefPubMedGoogle Scholar
  • 34 Iwahana H, Yoshimoto K, Itakura M. Highly polymorphic region of the human prothrombin (F2) gene. Hum Genet 1992; 89: 123-4.
    CrossrefPubMedGoogle Scholar
  • 35 Zivelin A, Rosenberg N, Faier S, Kornbrot N, Peretz H, Mannhalter C, Horellou MH, Seligsohn U. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 1998; 92: 1119-24.
    PubMedGoogle Scholar
  • 36 Woolf B. On estimating the relation between blood group and disease. Am J Hum Genet 1955; 19: 251-3.
    PubMedGoogle Scholar
  • 37 Ott J. Analysis of Human Genetic Linkage. Third Edition Baltimore and London: The John Hopkins University Press; 1999: 1-382.
    Google Scholar
  • 38 Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HH. Nonuniform recombination within the human beta-globin gene cluster. Am J Hum Genet 1984; 36: 1239-58.
    PubMedGoogle Scholar
  • 39 Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29: 311-22.
    CrossrefPubMedGoogle Scholar
  • 40 Nesic D, Cheng J, Maquat LE. Sequences within the last intron function in RNA 3′-end formation in cultured cells. Mol Cell Biol 1993; 13: 3359-69.
    CrossrefPubMedGoogle Scholar